← back to search

Daryle J. DePianto

Gene Therapy Laboratory · FR
Area of research
Pulmonary and Respiratory Medicine · Pathology and Forensic Medicine
Research interest
Research interests include Medicine, Fibrosis, Idiopathic pulmonary fibrosis, Lung, Biology, and Computer science.
h-index
citations
1,168
works
12
NIH funding
primary concept
email

Recent publications

Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosis
bioRxiv (Cold Spring Harbor Laboratory) 2025cited by 0position: middledoi
A cell atlas foundation model for scalable search of similar human cells
Nature 2024cited by 112position: middledoi
Oncostatin M expression induced by bacterial triggers drives airway inflammatory and mucus secretion in severe asthma
Science Translational Medicine 2022cited by 53position: middledoi
A WISP1 antibody inhibits MRTF signaling to prevent the progression of established liver fibrosis
Cell Metabolism 2022cited by 48position: middledoi
TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis
Science Translational Medicine 2021cited by 130position: middledoi
Molecular mapping of interstitial lung disease reveals a phenotypically distinct senescent basal epithelial cell population
JCI Insight 2021cited by 83position: firstdoi
Molecular programs of fibrotic change in aging human lung
Nature Communications 2021cited by 75position: middledoi
Osteopontin Links Myeloid Activation and Disease Progression in Systemic Sclerosis
Cell Reports Medicine 2020cited by 113position: middledoi
CXCL14 is a candidate biomarker for Hedgehog signalling in idiopathic pulmonary fibrosis
Thorax 2017cited by 61position: middledoi
Keratin-dependent regulation of Aire and gene expression in skin tumor keratinocytes
Nature Genetics 2015cited by 127position: middledoi
Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis
Thorax 2014cited by 303position: firstdoi
Endogenously Expressed IL-13Rα2 Attenuates IL-13–Mediated Responses but Does Not Activate Signaling in Human Lung Fibroblasts
The Journal of Immunology 2014cited by 63position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Paul J. Wolters · Netherlands Organisation for Applied Scientific Research6 papers (2014–2021)Joseph R. Arron · Atotech (United States)6 papers (2014–2021)Zora Modrušan · Genetic Technologies (Australia)4 papers (2014–2021)Alexander R. Abbas · BioScience Laboratories (United States)3 papers (2014–2017)Harold R. Collard · University of California, San Francisco3 papers (2014–2017)Jackson G. Egen · Gilead Sciences (United States)3 papers (2014–2017) · 3 papers (2014–2020)Sanjay Chandriani · Maze (United States)3 papers (2014–2017)Jason A. Vander Heiden · Acentech (United States)3 papers (2020–2024) · 3 papers (2014–2017)Michael A. Matthay · Drexel University2 papers (2014–2021)Katrina B. Morshead · Gene Therapy Laboratory2 papers (2020–2021)Kai-Hui Sun · Gilead Sciences (United States)2 papers (2020–2021) · 2 papers (2014–2014) · 2 papers (2014–2014)Liam Magee · University of California, San Francisco1 papers (2021–2021)Tobias Heigl · KU Leuven1 papers (2024–2024)Wenxin Zheng · Xinjiang Agricultural University1 papers (2015–2015)Héctor Corrada Bravo · Kaiser Permanente South San Francisco Medical Center1 papers (2024–2024) · 1 papers (2014–2014)